Careview Communications, Inc.
0.0300+0.00 (+0%)
Oct 29, 4:00:00 PM EDT · OTC Markets OTCQB · CRVW · USD
Key Stats
Market Cap
17.52MP/E (TTM)
-Basic EPS (TTM)
-0.01Dividend Yield
0%Recent Filings
8-K
Credit maturity extended
CareView Communications extended its credit agreement maturity to December 31, 2025, via the Twelfth Amendment effective September 30, 2025, with lender PDL Investment Holdings and executives Steven G. Johnson and Dr. James R. Higgins. This buys three months of breathing room on obligations under the 2015 pact. No new funds or rate changes disclosed. Lenders hold firm on existing terms.
10-Q
Q2 FY2025 results
CareView Communications swung to an operating profit of $198,771 in Q2 FY2025 ended June 30, 2025, up from a $319,053 loss a year earlier, while YTD operating income hit $64,061 versus a $552,439 deficit, fueled by total revenue climbing 20.6% y/y to $2.4M on stronger sales-based software bundles and 10.5% YTD to $4.6M. Gross margins aren't broken out, but operating expenses dipped 4.9% y/y to $2.2M amid lower human resources and deployment costs. Yet net loss narrowed to $589K from $1.1M, dragged by $802K interest expense on $20M PDL notes payable extended to September 30, 2025; diluted EPS held at $(0.00) across 584M shares with 67M anti-dilutive options excluded. Cash swelled to $1.8M, with operating cash flow at $1.1M and free cash flow of $1.0M after minimal $56K capex (derived). Debt looms large at $20.7M plus $21.3M accrued interest, underscoring liquidity strains. Revenue hinges on volatile sales-based contracts.
8-K
Credit maturity extended
CareView Communications extended its credit agreement maturity to September 30, 2025, via an eleventh amendment effective June 30, 2025, with lender PDL Investment Holdings and insiders Steven G. Johnson and Dr. James R. Higgins. This pushes back the deadline on existing obligations, easing near-term repayment pressure while the company reaffirms all liens and security interests. No new borrowings or fees detailed. Short-term liquidity holds.
10-Q
Q1 FY2025 results
CareView Communications nudged revenues up 1.6% year-over-year to $2.2M in Q1 FY2025 ended March 31, 2025, with sales-based software bundles surging 83.7% to $1.1M on recurring annual licenses, offsetting a 3.0% dip in subscription revenue to $991K; equipment sales fell sharply to $121K from $568K. Operating loss narrowed to $135K from $233K as expenses dropped 2.6% to $2.4M, driven by lower product deployment costs. Net loss improved 9.9% to $921K, though interest expense held steady at $802K, widening the gap from operating loss. Cash climbed to $1.0M with $287K from operations minus $20K capex, yielding $267K free cash flow (derived), yet $20M debt matures June 30, 2025, and a $42M working capital deficit signals liquidity strain. Debt extensions via troubled restructurings bought time. Substantial doubt lingers on funding without fresh capital.
10-K
FY2024 results
CareView Communications posted FY2024 revenue of $8.3M, down 15% y/y from $9.7M, as sales-based equipment deals dropped sharply while software bundles rose. Operating loss widened to $1.6M from $0.7M, driven by higher human resource costs from stock grants, yet net loss climbed to $4.8M versus $4.0M amid interest and other expenses. Q4 momentum faltered with overall revenue decline, but subscription backlog hit $4.2M annually, signaling steady recurring income. Cash dwindled to $0.8M after $0.2M operating burn, with $42M working capital deficit underscoring liquidity strains—no buybacks or dividends amid debt extensions. No 2025 guidance disclosed. Dependence on one customer for 19% of revenue risks quarterly volatility.
IPO
Website
Employees
Sector
Industry
AMWL
American Well Corporation
5.32-0.02
CMHSF
COMPREHENSIVE HEALTHCARE SYS IN
0.39+0.00
CTEV
Claritev Corporation
68.60-2.58
HSTM
HealthStream, Inc.
24.60-1.23
LVCE
LIVECARE INC
0.03+0.00
SPOK
Spok Holdings, Inc.
15.81-0.60
VEEV
Veeva Systems Inc.
286.67-4.68
VISL
Vislink Technologies, Inc.
2.47-0.11
VSEE
VSee Health, Inc.
1.38+0.32
WEAV
Weave Communications, Inc.
6.58-0.42